All Updates

All Updates

icon
Filter
Partnerships
Fluence and Enthea partner to expand access to ketamine-assisted therapy and practitioner training
Psychedelic Medicine
Jun 26, 2024
Last week:
M&A
Nscale acquires Kontena to enhance HPC and AI infrastructure capabilities
Generative AI Infrastructure
Yesterday
Product updates
Eve Air Mobility unveils unmanned eVTOL prototype
Passenger eVTOL Aircraft
Yesterday
Product updates
Lilium advances POWER-ON, providing solutions with leading digital innovators
Passenger eVTOL Aircraft
Yesterday
Product updates
Together AI unveils new inference stack and endpoints for improved speed and efficiency
Generative AI Infrastructure
Jul 20, 2024
Industry news
New South Korean space agency provides rundown of plans
Space Travel and Exploration Tech
Jul 20, 2024
Product updates
Micron Technology introduces high-performance MRDIMMs to improve bandwidth for AI and HPC applications
Generative AI Infrastructure
Jul 19, 2024
Management news
Bionano Genomics receives Nasdaq non-compliance notice; continues trading efforts
Precision Medicine
Jul 19, 2024
Funding
GRO Biosciences raises USD 60.3 million in Series B funding to advance lead program into clinical trials and expand GRObio pipeline
Precision Medicine
Jul 19, 2024
Management news
Yooz announces new appointments in C-Suite
Business Expense Management
Jul 19, 2024
Regulation/policy
Airwallex secures license to expand retail investment offerings in Australia
FinTech Infrastructure
Jul 19, 2024
Psychedelic Medicine

Psychedelic Medicine

Jun 26, 2024

Fluence and Enthea partner to expand access to ketamine-assisted therapy and practitioner training

Partnerships

  • Fluence, a company specializing in psychedelic therapy training, has partnered with Enthea, a health insurance administrator, to expand reimbursement for services from Fluence-trained clinicians offering ketamine-assisted therapy.

  • Under this partnership, clinicians meeting Enthea's requirements will receive a 20% discount on Fluence's Psychedelic Therapy Integration and Ketamine-Assisted Psychotherapy Certificate programs. The discount will increase to 30% if annual referrals exceed 100 participants. The collaboration aims to increase the accessibility of psychedelic-assisted therapy and expand the pool of trained therapists. 

  • Analyst QuickTake: In recent years, Fluence has been leveraging partnerships to expand its psychedelic-assisted therapy and practitioner training services. In May 2024 , Fluence partnered with Metamorph AI to develop a GenAI tool for psychedelic therapy training. Additionally, it partnered with several psychedelic research and development companies to offer training for psychedelic therapy, including Reunion Neuroscience (April 2024), Psyence (April 2024), and Cybin (September 2023).

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.